Tissue eosinophilia is a feature of idiopathic inflammatory bowel disease and other forms of colonic inflammation but it is not clear whether the role of eosinophils in the disease process is to contribute to tissue damage. Interleukin 5 (IL-5) stimulates production and activation of eosinophils in vitro and enhances immunoglobulin A (IgA) production. As very little is known about the function of IL-5 in the colon, the aim of this study was to assess its role in colonic inflammation. IL-5 deficient mice were studied using the dextran sulphate sodium (DSS)-induced colitis model and the results compared to a congenic IL-5+/+ strain. The absence of IL-5 resulted in reduction of tissue eosinophilia (P Ͻ 0.0001) but was not reflected in differences in the severity of the disease (P Ͼ 0.5) or in the extent of tissue damage in this model of colitis. Numbers of immunoglobulin-containing cells in IL-5 deficient mice were similar to those in the IL-5+ mice. We conclude that the main role of IL-5 in DSS-induced colonic inflammation is to attract a population of eosinophils which do not appear to contribute significantly to the initiation or development of tissue damage in this model of colitis. Genes and Immunity (2000) 1, 213-218.
Introduction
Ulcerative colitis is a disease of unknown aetiology characterised by a chronic relapsing course. The disease can be induced experimentally in mice by dextran sulphate sodium (DSS) given in the drinking water. 1 Our studies using this model have confirmed that the histopathological changes that are induced by this method resemble ulcerative colitis.
Infiltration by eosinophils into the inflamed areas of the colon is a feature of both the clinical disease and the model of DSS-induced colitis (see below). The eosinophil lineage appears to be specifically regulated by interleukin 5 (IL-5), a cytokine produced by the T helper 2 subset (Th2) as well as by eosinophils and mast cells. 2 Although earlier studies suggested additional activities of IL-5 in regulating mouse B cells and antibody production 3 recent studies with an IL-5 deficient mouse strain indicate that the regulation of eosinophilia may be the only obligatory role for IL-5 in the adult mouse. 4 IL-5 deficient mice, produced by gene targeting of embryonal stem cells, 4 appear to be normal in appearance and do not develop any obvious disease. Tissue eosinophilia induced by parasitic infections is abolished in these mice although baseline numbers of eosinophils are close to normal. Since the role of IL-5 in the mucosal lesion of ulcerative colitis is not known, in this paper we explore the function of IL-5 in a mouse model of colitis using IL-5 deficient mice. Our findings suggest a role for IL-5 in eosinophil recruitment in acute colonic inflammation but indicate that IL-5 deficiency does not affect the course of the disease or the number of immunoglobulin-producing cells in the mucosa.
Results
The results described below comprise a summary of a total of five experiments.
IL-5 influences eosinophil infiltration
Baseline eosinophil numbers in the colon of healthy IL-5 deficient mice varied from 0 to an average of 0.25 cells per transverse section of the colon and were significantly lower (P = 0.0001) than in the congenic strain (2.08 to 3.6). Eosinophil numbers increased in both strains during the course of the DSS-induced colitis. Administration of 5% DSS was associated with lower eosinophil counts in IL-5 deficient mice compared to the congenic strain, a difference which was not statistically significant (P = 0.079). Eosinophils were very low or absent in IL-5 deficient mice exposed to 2.5% DSS (Figure 1 ). The 2.5% DSS induced a significantly higher eosinophil count at day 9 in the IL-5+/+ mice (P = 0.0001) compared to the congenic IL-5 deficient strain (Figure 1 ). Representative data in Figure 1 show the number of eosinophils at different time points during the course of the disease. The absence of IL-5 did not completely suppress the eosinophil infiltration into the colon suggesting that a minor proportion of the infiltrating eosinophil population was not IL-5 dependent. Eosinophilic infiltration in the colon was not Figure 1 Eosinophil counts in the colon. Eosinophil counts were performed in IL-5 deficient mice and the congenic IL-5+/+ strain before and on 4, 7 and 9 days after exposure to DSS. Similar results were obtained in five consecutive experiments. (a) Eosinophil counts in mice exposed to 2.5% DSS; (b) eosinophil counts in mice exposed to 5% DSS.
provoked by the high numbers of macrophages and their products. Macrophage numbers ranged from 2.60 ± 0.77 (mean ± standard deviation) in the 2.5% DSS-induced colitis and 2.75 ± 1.23 in the 5% DSS-induced colitis in the IL-5+/+ strain, to 3.62 ± 1.42 in the 2.5% DSS-induced colitis and 2.63 ± 1.13 in the 5% DSS-induced colitis in the IL-5 deficient mice indicating that there was no significant difference between IL-5 deficient mice and the congenic strain.
IL-5 deficiency does not affect the severity of the colitis
Dextran sulphate sodium-induced colitis develops as an acute inflammation affecting predominantly the left colon and rectum. The first signs of inflammation are apparent after 3 days exposure to DSS and present clinically as progressive weight loss. Subsequently, mice develop diarrhoea and rectal bleeding. After ingestion of 2.5% or 5% DSS the course of the disease in IL-5 deficient mice was no different to that seen in the congenic IL-5+/+ strain ( Figure 2) .
Histological examination did not show any significant differences in the distribution of the colitis or in the severity of tissue damage. Ulceration developed in both mouse strains to a similar extent. The histological score, a quantitative measure of the severity of tissue damage was no different in IL-5 deficient mice (11.25 ± 0.96) compared to IL-5+/+ control mice (10.60 ± 1.67, P = 0.4).
Figure 2
Activity of the disease during the course of DSS-induced colitis. Activity of the disease was measured by the disease activity index at day 4, 7 and 9 of the disease. The severity of the colitis was not significantly different in the IL-5 deficient mice compared to the IL-5+ congenic strain regardless of the concentration of DSS used to induce colitis (P = 0.6 and P = 0.62). (a) Disease activity index in mice exposed to 2.5% DSS (n = 25); (b) disease activity index in mice exposed to 5% DSS (n = 24).
These findings indicate that IL-5 does not influence significantly the severity or the outcome of colonic inflammation in this model.
IL-5 does not influence immunoglobulin-containing cell numbers in the mucosa
Immunofluorescent staining for immunoglobulincontaining cells in the colonic mucosa was performed in both mouse strains. Baseline numbers of immunoglob- -containing cells in the inflamed colon of IL-5 deficient mice and the congenic IL-5+/+ strain (Table 1) . By contrast, colitis induced by 5% DSS resulted in a significant reduction (P = 0.04) of the numbers of total immunoglobulin-containing cells as well as in reduced expression of IgA and IgG-expressing cells. The table shows the decrease in the number of immunoglobulin-containing cells at day 8 of the disease compared to the healthy colon before the administration of dextran. The reason for the difference in Ig-containing cell numbers when two concentrations of DSS are used is unclear.
Discussion
The results described in this study suggest that the main role of IL-5 in colonic inflammation is to promote the infiltration of eosinophils into the colon. The absence of changes in the population of immunoglobulin-containing cells indicates that IL-5 may not have an obligatory role in mucosal IgA and IgG production in vivo. This contrasts with the effects of IL-5 previously observed 'in vitro'. [5] [6] [7] In mice, the main activities of IL-5 involve eosinophils and B cells whereas in humans, IL-5 principally affects the eosinophil lineage but its effects on B cells remain controversial. IL-5 does not appear to influence small resting cells but stimulates large pre-activated B cells, inducing proliferation and secretion of immunoglobulins in vitro.
5 IL-5 also enhances secretion of IgA by precommitted B cells 6 and affects IgG production by antigenprimed B cells. 7 In addition, IL-5 stimulates the production of eosinophils in cultures of human bone marrow, 8 acts as a chemo-attractant for mature murine eosinophils and induces superoxide anion production. 9 Much less however is known about the activity of IL-5 in vivo. This paper explores the role of this cytokine in the DSS-induced mouse model of acute ulcerative colitis. IL-5 did not influence immunoglobulin-containing cell numbers in the intestine during the course of DSSinduced colitis nor does it appear to be necessary for antibody production. These findings confirm findings by Kopf et al 4 that IL-5 does not have an obligatory role in either B cell growth or antibody production in vivo. The levels of colonic eosinophils in healthy IL-5 deficient mice were lower than in controls and despite an increase during the course of the disease there was a significant reduction in eosinophil numbers infiltrating the colon at day 9 in animals exposed to 2.5% DSS in the absence of IL-5. These findings indicate that IL-5 contributes to the colonic inflammatory lesion mainly via its action on eosinophils. However, the attenuation of eosinophil infiltration resulting from the absence of IL-5 does not result in a corresponding change in the extent or severity of tissue damage, raising questions about the effects of the eosinophil in inflammation. Similarly, the absence of IL-5 appeared to have no effect on the numbers of immunoglobulin-containing cells indicating that IL-5 is not essen- tial to the regulation of IgA and IgG production in vivo in the inflamed intestinal mucosa. Increased numbers of mucosal eosinophils in inflammatory bowel disease (IBD) have been reported in several studies. While the mucosal eosinophil count is higher than in normal control subjects in cases of long standing ulcerative colitis, in a severe first attack of ulcerative colitis, the number of eosinophils is not significantly higher from control levels. 10 It has been suggested that the role of eosinophils in ulcerative colitis may be inhibitory or regulatory.
11 Heatley and James 12 have shown that a high eosinophil count in the rectal biopsy indicates a relatively good prognosis, the colitis being self-limiting or easily controlled with medical therapy.
With regard to animal models of ulcerative colitis, high eosinophil counts are present in carageenan-induced colitis 13 and in the present studies we demonstrated increased numbers of eosinophils in the inflammatory infiltrate in DSS-induced colitis. The numbers of eosinophils are much higher if the colitis is induced by a lower concentration of DSS although the significance of this finding is unclear. Macrophages and their products are important factors in the recruitment of eosinophils 14, 15 but we did not demonstrate any difference in numbers of macrophages in the inflammatory infiltrate between IL-5 deficient mice and controls. Our results, however indicate that the recruitment of eosinophils to the inflamed region is influenced by the activity of IL-5 but that the reduced eosinophil responses in IL-5 deficient mice did not alter the severity of the disease or the extent of tissue damage. These findings suggest that neither the eosinophil nor IL-5 contributes significantly to tissue damage nor does it induce a protective immunological response in the inflamed colon. While their exact roles is yet to be determined this study deals with the acute phase of DSSinduced colitis some of which may not be mediated immunologically. Further studies are needed to determine the impact of eosinophils and IL-5 in more chronic phases of inflammation.
Materials and methods
Mice IL-5 deficient mice were generated in C57Bl/6 stem cells by gene targeting and were regularly checked for IL-5 deficiency. 4 Homozygous animals were obtained by breeding of heterozygous parents and were identified by polymerase chain reaction analysis. Mice were fed sterile food and water ad libitum and were regularly checked for viruses and parasites. The studies were approved by The Animal Experimentation Ethics Committee of The Australian National University.
Dextran sulphate sodium
The dextran sulphate sodium used was a sodium salt of molecular weight of 41 K and with sulphur substitution of 16.3 (TdB Consultancy, Uppsala, Sweden). DSS was given as 2.5% and 5% solutions in distilled water for 8 days.
Disease activity index
Disease activity index (DAI) was derived from the three major clinical signs (weight loss, diarrhoea and rectal bleeding) as previously described. 16 The clinical signs were analysed separately and correlated with the histological score. The final formula for the DAI was evaluated by correlation with the histological score. The DAI was defined as: DAI = (weight loss) + (diarrhoea score) + (rectal bleeding score).
Body weight loss:
Body weight loss was calculated as the difference between the predicted body weight and the actual body weight on a particular day. The formula for predicted body weight was derived by simple regression using the body weight data for the control group. The following formula was derived: Y = a + kx, where Y = body weight change (loss or gain), k = daily increase in body weight, x = day, a = starting body weight. The daily increase in body weight (k) was 0.251 for the IL-5+/+ strain and 0.242 for the IL-5 deficient mouse strain.
Diarrhoea:
The appearance of diarrhoea was defined as mucus/faecal material adherent to anal fur. The presence or absence of diarrhoea was scored as either 1 or 0 respectively. The cumulative score for diarrhoea was calculated by adding the score for each day and dividing this number by the number of days of exposure.
Rectal bleeding: The appearance of rectal bleeding was defined as diarrhoea containing blood or mucus or frank rectal bleeding. The final score for rectal bleeding was calculated as described for diarrhoea.
Histopathological examination and scoring
Tissue specimens were fixed in 10% neutral formalin and embedded in paraffin. Colons were divided into right, transverse and left and specimens stained with haematoxylin and eosin. Histological examination was performed on serial sections. The most affected part of the colon was scored blindly using a standard 12-point histological scoring system.
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Eosinophil counts
Eosinophil counts were performed on serial, Giemsastained, 4 thick, transverse sections of the left colon and were expressed as the average eosinophil count per full transverse section of the colon. The results were confirmed by additional counts per high power field (×250 magnification) and by counting the numbers of eosinophils per cm 2 of lamina propria using video image analysis.
Immunofluorescent staining
The specimens were fixed using cold ethanol, 18 embedded in paraffin and 5 sections cut on to gelatine-coated slides. Immunoglobulin-containing cells were detected by immunofluorescence as previously described. 19 Briefly, tissues were dewaxed, rehydrated and then incubated with goat anti-mouse IgA (␣ chain specific) (SeraLab, Crawley Down, Sussex, UK), followed by tetramethylrhodamine-isothiocyanate (TRITC)-conjugated rabbit anti-goat immunoglobulin (Atlantic Antibodies, Scarborough, ME, USA) for detection of IgA-containing cells; fluorescein isothiocyanate (FITC) conjugated goat anti-mouse IgM ( chain specific) (Cappel, Durham, NC, USA) for detection of IgM-containing cells; FITC-conjugated mouse monoclonal antibody against mouse IgG (␥-chain specific) (SeraLab); or FITC-conjugated mouse monoclonal antibody against mouse IgE (ε-chain specific) (SeraLab). Following each 20-min incubation, excess reagent was removed and the slides rinsed in phosphate buffered saline (PBS). Finally slides were rinsed for 1 h in PBS and mounted using 90% glycerol in PBS. The number of Ig-containing cells in the intestine were counted using a 40× objective and 10× eyepieces using a Zeiss Axioskop 20 microscope with incident light illumination. Each section of the intestine was scanned from the tips of the villi to the base of the mucosa, and cells were counted in a total of 30 such scans. The average number of cells per scan was expressed as cells per linear cm of intestine by multiplying by 30.3, a correction factor determined from the field width of 330 m, as previously described. 20 
Counting of macrophages
Immunocytochemistry: Periodate-lysine-paraformaldehyde (PLP)-fixed tissues were embedded in OCT compound (Miles Inc, Diagnostic Division, Pymble, NSW, Australia). Transverse, serial, 6 thick sections of the colon were washed in PBS 2 × 5 min to remove OCT. Non-specific Fc binding was blocked by incubating with goat anti-mouse IgG (H+L) (Caltag Immunodiagnostics, St Peters, NSW, Australia) 100 l/10 ml PBS and 2% sheep serum for 30 min. The macrophage-specific monoclonal antibody F4/80 (1:3 in PBS) 21 was used as a primary antibody and applied after the blocking step. No primary antibody and isotype control IgG 2b (Pharmingen, Lane Cove, NSW, Australia) were used as negative controls. Following 60 min incubation at room temperature, slides were rinsed in PBS 2 × 5 min. Endogenous peroxidase activity was blocked by 0.1% hydrogen peroxide in methanol for 10 min after dehydrating the sections in ethanol. Slides were rehydrated in ethanol and washed 2 × 5 min in PBS. Biotinylated sheep anti-rat antibody (Amersham, Castle Hill, NSW, Australia, 1:200 in PBS) was applied as a secondary antibody. Following 30 min incubation and 2 × 5 min washing in PBS the avidin-biotin complex system (ABC kit, Vectastain, Vector Laboratories, Inc, Rockdale, NSW, Australia) was used to detect the relevant Genes and Immunity antigen. Di-aminobenzidine (DAB, 1:5 in PBS combined with 1 ml imidazole and 15 l H 2 O 2 ) was used as a substrate and was applied for 10 min following the 30 min incubation in ABC and 2 × 5 min. washing in PBS. Tissue sections were washed in water for 3 min and counterstained using haematoxylin.
Counting of positive cells: F 4/80 positive cells were counted using the NIH 1.55 video image analysis program and were expressed as the number of positive cells per mm 2 lamina propria. Only the lamina propria was marked and its surface area measured. Crypts and epithelial cells were not included in this calculation. The results of the area measurement were corrected for the magnification of the microscope and the screen.
